MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Colleagues,

As always thanx to our friends at OnBioVC for their excellent & timely update analysis of the U.S. bioscience venture capital markets.

The OnBioVC tracked 35 bioscience related venture capital financings in June 2009 versus 24 deals in June ‘08. The June 2009 bioscience investment proceeds totaled approximately $547.1M, an increase of roughly $103.9M compared to the $443.2M for June 2008, a month-over-month investment increase of ~23%.

OnBioVC believes they may see a trend in the 7 Cardiovascular device deals that closed,
accounting for $77.4M in June 2009. But, these investment rounds were mainly later stage investments with (2) Series B financing rounds, (2) late-stage C Series rounds, and (3) Series D financing rounds.

OnBioVC notes that the device dominance did not end with Cardiovascular, there were 22 medical device deals out of 35 total in June 2009. This gained medical devices the leading investment sector status at $267m for the month. Geographically, California continued to dominate venture capital investment wih 9 financings in June 2009...

Read on/Comment: http://onbiovc.com/wp-content/uploads/2009/07/onbiovc-trend-analysi...

ENJOY!

CC

Views: 0

© 2024   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service